+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Inhalation Sevoflurane Anesthesia Drugs Market - Global Forecast 2026-2032- Product Image
Inhalation Sevoflurane Anesthesia Drugs Market - Global Forecast 2026-2032- Product Image
Sale

Inhalation Sevoflurane Anesthesia Drugs Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6126391
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Inhalation Sevoflurane Anesthesia Drugs Market is projected to reach USD 1.39 Billion in 2026. It is expected to continue growing at a CAGR of 9.62%, reaching USD 2.43 Billion by 2032.

Introduction to Inhalation Sevoflurane Anesthesia Drugs

Inhalation sevoflurane anesthesia drugs are volatile anesthetic medicines administered through anesthesia machines for induction and maintenance of general anesthesia. Their clinical use is associated with rapid adjustment of anesthetic depth, low airway irritation relative to some older inhaled agents, and suitability for mask induction in selected patients. Use is shaped by surgical activity, anesthesia practice, medicine regulation, operating-room infrastructure, procurement policies, and requirements for safe handling and waste-gas control.

Transformative Shifts in Inhalation Anesthesia Practice

The landscape is changing through wider adoption of standardized perioperative pathways, greater attention to rapid recovery, and stronger environmental controls for anesthetic gases. Hospitals are emphasizing closed-loop or low-flow techniques, vaporizer accuracy, scavenging systems, staff training, and medication traceability. At the same time, supply resilience has become more important because interruptions in sterile pharmaceutical manufacturing, packaging, distribution, or hospital procurement can affect procedure scheduling and clinical continuity.

Artificial Intelligence’s Cumulative Impact on Sevoflurane Use

Artificial intelligence is increasingly relevant to inhalation anesthesia through decision support, physiologic monitoring, workflow optimization, and predictive maintenance. Algorithms can help clinicians interpret trends in depth of anesthesia, ventilation, hemodynamics, and recovery readiness, but they do not replace professional judgment or validated monitoring. Additional applications include forecasting operating-room demand, identifying equipment anomalies, supporting inventory management, and analyzing emissions data. Safe implementation requires high-quality data, transparent validation, cybersecurity controls, human oversight, and compliance with medical-device and pharmaceutical regulations.

Regional Insights Across Global Anesthesia Systems

North America is characterized by advanced operating-room infrastructure, formal medication-safety programs, and growing attention to low-flow delivery and environmental stewardship. Europe combines mature surgical systems with stringent pharmaceutical, device, occupational-safety, and emissions requirements. Asia-Pacific presents diverse conditions, ranging from highly equipped urban hospitals to facilities where access to anesthesia machines, trained personnel, and reliable supply chains remains uneven. Latin America is influenced by public-private health-system differences, import dependence in some settings, and efforts to expand surgical access. The Middle East is investing in tertiary and specialized care while prioritizing standards-based procurement and workforce development. Africa includes substantial variation in surgical capacity, oxygen and equipment reliability, anesthetist availability, and medicine access, making infrastructure and training central to safe adoption.

Group-Level Dynamics Across ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN markets reflect varied regulatory systems, healthcare financing models, and levels of operating-room readiness, with regional cooperation supporting supply-chain and workforce resilience. BRICS members span large and diverse health systems, creating opportunities for local manufacturing, standardized protocols, and expanded surgical capacity while retaining significant differences in infrastructure and access. The European Union emphasizes harmonized regulation, procurement quality, and environmental performance. G7 countries generally operate mature anesthesia services with strong safety surveillance and data capabilities. GCC health systems are developing advanced hospital capacity and specialized care, while NATO members may also consider continuity of medical logistics and resilience during emergencies. These groupings are heterogeneous and should not be treated as uniform commercial or clinical markets.

Country Perspectives on Sevoflurane Anesthesia Drugs

Australia and Canada have mature perioperative systems with emphasis on clinical governance, stewardship, and supply continuity. Brazil and Mexico combine sophisticated urban hospitals with unequal access across regions. China and India have large and diverse surgical ecosystems, with expanding infrastructure alongside substantial variation among provinces, states, and facility types. France, Germany, Italy, Spain, and the United Kingdom operate regulated healthcare systems where procurement, safety monitoring, and environmental considerations influence practice. Japan and South Korea have advanced hospital technology and aging-population care needs that support demand for efficient perioperative services. Russia’s healthcare environment is shaped by domestic production, import controls, and logistical considerations. In the United States, hospital protocols, accreditation expectations, supply resilience, and cost-conscious procurement strongly influence utilization.

Strategic Priorities for Industry Leaders

Industry leaders should prioritize reliable pharmaceutical quality, diversified sourcing, and transparent continuity planning. Product stewardship should include clear handling guidance, vaporizer compatibility information, waste-gas mitigation, and evidence-based support for low-flow use where clinically appropriate. Partnerships with hospitals and professional organizations can strengthen education on dosing, monitoring, recovery, and incident prevention. Investment in interoperable data systems may improve inventory visibility and equipment maintenance, while any artificial-intelligence application should be clinically validated and governed by robust privacy, cybersecurity, and accountability controls. Regional strategies should be adapted to regulatory requirements, infrastructure constraints, workforce capability, and public-health priorities rather than relying on a single global approach.

Research Methodology for the Executive Summary

This executive summary uses the specified market scope- inhalation sevoflurane anesthesia drugs-and organizes findings across the requested regions, country groupings, and countries. The assessment is based on triangulation of publicly available regulatory information, clinical and pharmacological literature, hospital-practice evidence, health-system and surgical-capacity indicators, procurement and supply-chain context, and documented developments in anesthesia technology. Qualitative conclusions are limited to observable industry, clinical, regulatory, infrastructure, and technology factors. No market estimates, market sizing, market shares, or forecasts are used.

Conclusion: Building Safe, Resilient, and Sustainable Use

The sevoflurane anesthesia-drug landscape is being shaped by clinical performance requirements, surgical access, medicine quality, operating-room capability, supply resilience, and environmental responsibility. Regional and country conditions differ materially, so effective strategies must combine dependable products with training, monitoring, equipment readiness, and regulatory alignment. Artificial intelligence can strengthen planning and decision support when deployed cautiously, transparently, and under clinician oversight. Leaders that integrate patient safety, operational continuity, responsible gas management, and evidence-based innovation will be best positioned to support durable use across varied healthcare systems.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Inhalation Sevoflurane Anesthesia Drugs Market, by Product Type
7.1. Introduction
7.2. Bulk Liquid
7.3. Ready To Use
8. Inhalation Sevoflurane Anesthesia Drugs Market, by Application
8.1. Introduction
8.2. Ambulatory Anesthesia
8.3. General Anesthesia
8.3.1. Cardiac Surgery
8.3.2. Inpatient Surgery
8.3.3. Neurosurgery
8.4. Pediatric Anesthesia
8.4.1. Day Care
8.4.2. Inpatient
8.5. Veterinary
9. Inhalation Sevoflurane Anesthesia Drugs Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Clinics
9.4. Home Care Settings
9.5. Hospitals
9.5.1. Government Hospitals
9.5.2. Private Hospitals
10. Inhalation Sevoflurane Anesthesia Drugs Market, by Distribution Channel
10.1. Introduction
10.2. Offline
10.3. Online
11. Inhalation Sevoflurane Anesthesia Drugs Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Inhalation Sevoflurane Anesthesia Drugs Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Inhalation Sevoflurane Anesthesia Drugs Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. AbbVie Inc.
15.3. Anhil Parenterals Pvt. Ltd.
15.4. AstraZeneca plc
15.5. B. Braun Melsungen AG
15.6. Baxter International Inc.
15.7. Fresenius Kabi AG
15.8. Gujarat Medicraft Private Limited
15.9. Halocarbon Life Sciences, LLC
15.10. Hikma Pharmaceuticals PLC
15.11. Jiangsu Hengrui Pharmaceuticals Co., Ltd.
15.12. Lunan Pharmaceutical Group Co., Ltd.
15.13. Maruishi Pharmaceutical Co., Ltd.
15.14. Mylan N.V.
15.15. Neon Laboratories Ltd.
15.16. Novartis AG
15.17. Piramal Enterprises Ltd.
15.18. Questus Pharma Pvt. Ltd.
15.19. Shanghai Hengrui Pharmaceutical Co., Ltd.
15.20. Troikaa Pharmaceuticals Ltd.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Inhalation Sevoflurane Anesthesia Drugs Market, Years Considered for the Study
FIGURE 2. Global Inhalation Sevoflurane Anesthesia Drugs Market, Research Design
FIGURE 3. Global Inhalation Sevoflurane Anesthesia Drugs Market, Research Framework
FIGURE 4. Global Inhalation Sevoflurane Anesthesia Drugs Market, Data Triangulation
FIGURE 5. Global Inhalation Sevoflurane Anesthesia Drugs Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Inhalation Sevoflurane Anesthesia Drugs Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Inhalation Sevoflurane Anesthesia Drugs Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Inhalation Sevoflurane Anesthesia Drugs Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Inhalation Sevoflurane Anesthesia Drugs Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Inhalation Sevoflurane Anesthesia Drugs Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Inhalation Sevoflurane Anesthesia Drugs Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Inhalation Sevoflurane Anesthesia Drugs Market Segmentation & Coverage
TABLE 2. Global Inhalation Sevoflurane Anesthesia Drugs Market Size, 2017-2032 (USD Million)
TABLE 3. Global Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Bulk Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Bulk Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Bulk Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Ready To Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Ready To Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Ready To Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 11. Global Ambulatory Anesthesia Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Ambulatory Anesthesia Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Ambulatory Anesthesia Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global General Anesthesia Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global General Anesthesia Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global General Anesthesia Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Cardiac Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Cardiac Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Cardiac Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Inpatient Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Inpatient Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Inpatient Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Neurosurgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Neurosurgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Neurosurgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Pediatric Anesthesia Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Pediatric Anesthesia Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Pediatric Anesthesia Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Day Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Day Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Day Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Inpatient Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Inpatient Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Inpatient Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Veterinary Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Veterinary Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Veterinary Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 39. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Home Care Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Home Care Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Home Care Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Government Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Government Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Government Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 58. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Inhalation Sevoflurane Anesthesia Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Inhalation Sevoflurane Anesthesia Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 73. North America Inhalation Sevoflurane Anesthesia Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. North America Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 75. North America Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 76. North America Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 77. North America Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 78. North America Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 79. North America Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 80. North America Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 81. Latin America Inhalation Sevoflurane Anesthesia Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Latin America Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 83. Latin America Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 84. Latin America Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 85. Latin America Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 86. Latin America Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 87. Latin America Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 88. Latin America Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 89. Europe Inhalation Sevoflurane Anesthesia Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Europe Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 91. Europe Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 92. Europe Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 93. Europe Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 94. Europe Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 95. Europe Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 96. Europe Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 97. Middle East Inhalation Sevoflurane Anesthesia Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Middle East Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 99. Middle East Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 100. Middle East Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 101. Middle East Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 102. Middle East Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 103. Middle East Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 104. Middle East Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 105. Africa Inhalation Sevoflurane Anesthesia Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Africa Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 107. Africa Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 108. Africa Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 109. Africa Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 110. Africa Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. Africa Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 112. Africa Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 113. Global Inhalation Sevoflurane Anesthesia Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. ASEAN Inhalation Sevoflurane Anesthesia Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. ASEAN Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 116. ASEAN Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 117. ASEAN Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 118. ASEAN Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 119. ASEAN Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. ASEAN Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 121. ASEAN Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 122. GCC Inhalation Sevoflurane Anesthesia Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. GCC Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 124. GCC Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. GCC Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 126. GCC Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 127. GCC Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. GCC Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 129. GCC Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 130. European Union Inhalation Sevoflurane Anesthesia Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. European Union Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 132. European Union Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 133. European Union Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 134. European Union Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 135. European Union Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. European Union Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 137. European Union Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 138. BRICS Inhalation Sevoflurane Anesthesia Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. BRICS Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 140. BRICS Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. BRICS Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 142. BRICS Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 143. BRICS Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 144. BRICS Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 145. BRICS Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 146. G7 Inhalation Sevoflurane Anesthesia Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. G7 Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 148. G7 Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. G7 Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 150. G7 Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 151. G7 Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. G7 Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 153. G7 Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 154. NATO Inhalation Sevoflurane Anesthesia Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. NATO Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 156. NATO Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 157. NATO Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 158. NATO Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 159. NATO Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 160. NATO Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 161. NATO Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 162. Global Inhalation Sevoflurane Anesthesia Drugs Market Size, by Country, 2017-2032 (USD Million)
TABLE 163. United States Inhalation Sevoflurane Anesthesia Drugs Market Size, 2017-2032 (USD Million)
TABLE 164. United States Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 165. United States Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 166. United States Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 167. United States Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 168. United States Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. United States Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 170. United States Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 171. Canada Inhalation Sevoflurane Anesthesia Drugs Market Size, 2017-2032 (USD Million)
TABLE 172. Canada Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 173. Canada Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. Canada Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 175. Canada Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 176. Canada Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. Canada Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 178. Canada Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 179. Mexico Inhalation Sevoflurane Anesthesia Drugs Market Size, 2017-2032 (USD Million)
TABLE 180. Mexico Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 181. Mexico Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 182. Mexico Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 183. Mexico Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 184. Mexico Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. Mexico Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 186. Mexico Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 187. Brazil Inhalation Sevoflurane Anesthesia Drugs Market Size, 2017-2032 (USD Million)
TABLE 188. Brazil Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 189. Brazil Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. Brazil Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 191. Brazil Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 192. Brazil Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. Brazil Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 194. Brazil Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 195. United Kingdom Inhalation Sevoflurane Anesthesia Drugs Market Size, 2017-2032 (USD Million)
TABLE 196. United Kingdom Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 197. United Kingdom Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 198. United Kingdom Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 199. United Kingdom Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 200. United Kingdom Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. United Kingdom Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 202. United Kingdom Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 203. Germany Inhalation Sevoflurane Anesthesia Drugs Market Size, 2017-2032 (USD Million)
TABLE 204. Germany Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 205. Germany Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 206. Germany Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 207. Germany Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 208. Germany Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. Germany Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 210. Germany Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 211. France Inhalation Sevoflurane Anesthesia Drugs Market Size, 2017-2032 (USD Million)
TABLE 212. France Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 213. France Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. France Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 215. France Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 216. France Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. France Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 218. France Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 219. Russia Inhalation Sevoflurane Anesthesia Drugs Market Size, 2017-2032 (USD Million)
TABLE 220. Russia Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 221. Russia Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. Russia Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 223. Russia Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 224. Russia Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. Russia Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 226. Russia Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 227. Italy Inhalation Sevoflurane Anesthesia Drugs Market Size, 2017-2032 (USD Million)
TABLE 228. Italy Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 229. Italy Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 230. Italy Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 231. Italy Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 232. Italy Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. Italy Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 234. Italy Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 235. Spain Inhalation Sevoflurane Anesthesia Drugs Market Size, 2017-2032 (USD Million)
TABLE 236. Spain Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 237. Spain Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 238. Spain Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 239. Spain Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 240. Spain Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. Spain Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 242. Spain Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 243. China Inhalation Sevoflurane Anesthesia Drugs Market Size, 2017-2032 (USD Million)
TABLE 244. China Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 245. China Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 246. China Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 247. China Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 248. China Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. China Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 250. China Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 251. India Inhalation Sevoflurane Anesthesia Drugs Market Size, 2017-2032 (USD Million)
TABLE 252. India Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 253. India Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. India Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 255. India Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 256. India Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 257. India Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 258. India Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 259. Japan Inhalation Sevoflurane Anesthesia Drugs Market Size, 2017-2032 (USD Million)
TABLE 260. Japan Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 261. Japan Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 262. Japan Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 263. Japan Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 264. Japan Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 265. Japan Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 266. Japan Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 267. Australia Inhalation Sevoflurane Anesthesia Drugs Market Size, 2017-2032 (USD Million)
TABLE 268. Australia Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 269. Australia Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 270. Australia Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 271. Australia Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 272. Australia Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 273. Australia Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 274. Australia Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 275. South Korea Inhalation Sevoflurane Anesthesia Drugs Market Size, 2017-2032 (USD Million)
TABLE 276. South Korea Inhalation Sevoflurane Anesthesia Drugs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 277. South Korea Inhalation Sevoflurane Anesthesia Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 278. South Korea Inhalation Sevoflurane Anesthesia Drugs Market Size, by General Anesthesia, 2017-2032 (USD Million)
TABLE 279. South Korea Inhalation Sevoflurane Anesthesia Drugs Market Size, by Pediatric Anesthesia, 2017-2032 (USD Million)
TABLE 280. South Korea Inhalation Sevoflurane Anesthesia Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 281. South Korea Inhalation Sevoflurane Anesthesia Drugs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 282. South Korea Inhalation Sevoflurane Anesthesia Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 283. Global Inhalation Sevoflurane Anesthesia Drugs Market Share, by Key Player, 2025
TABLE 284. Global Inhalation Sevoflurane Anesthesia Drugs Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc.
  • Anhil Parenterals Pvt. Ltd.
  • AstraZeneca plc
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Fresenius Kabi AG
  • Gujarat Medicraft Private Limited
  • Halocarbon Life Sciences, LLC
  • Hikma Pharmaceuticals PLC
  • Jiangsu Hengrui Pharmaceuticals Co., Ltd.
  • Lunan Pharmaceutical Group Co., Ltd.
  • Maruishi Pharmaceutical Co., Ltd.
  • Mylan N.V.
  • Neon Laboratories Ltd.
  • Novartis AG
  • Piramal Enterprises Ltd.
  • Questus Pharma Pvt. Ltd.
  • Shanghai Hengrui Pharmaceutical Co., Ltd.
  • Troikaa Pharmaceuticals Ltd.

Related Topics

Related Reports

Inhalation Sevoflurane Anaesthetic Agent Market - Global Forecast 2026-2032 - Product Image

Inhalation Sevoflurane Anaesthetic Agent Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Sevoflurane Anesthesia Drugs Market - Global Forecast 2026-2032 - Product Image

Sevoflurane Anesthesia Drugs Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Inhalation Anesthetics Market Outlook 2026-2034: Market Share, and Growth Analysis by Type (Desflurane, Sevoflurane, Isoflurane, Other Types), End User - Product Image

Inhalation Anesthetics Market Outlook 2026-2034: Market Share, and Growth Analysis by Type (Desflurane, Sevoflurane, Isoflurane, Other Types), End User

  • Report
  • 160 Pages
  • Global
From
Inhalation Anesthesia Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034 - Product Image

Inhalation Anesthesia Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034

  • Report
  • 147 Pages
  • Global
From
Anesthesia Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Anesthesia Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.